Prolintane

DB13438ExperimentalSmall molecule

Prolintane: Overview.

Mechanism: Pharmacologically active on Sodium-dependent noradrenaline transporter and Sodium-dependent dopamine transporter
Curator reviewed
Formula / weight: C₁₅H₂₃N · 217.3498 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyOJCPSBCUMRIPFL-UHFFFAOYSA-NSMILESCCCC(CC1=CC=CC=C1)N1CCCC1

Targets

Transporters

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

1ATC codeIncluding every combination product, plus 5 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Prolintane, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.